首页>
外文期刊>Journal of Medicinal Chemistry
>Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction (vol 65, pg 11485, 2022)
【24h】
Discovery of AZD4831, a Mechanism-Based Irreversible Inhibitor of Myeloperoxidase, As a Potential Treatment for Heart Failure with Preserved Ejection Fraction (vol 65, pg 11485, 2022)